Matilda Rentoft
Umeå University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Matilda Rentoft.
Proceedings of the National Academy of Sciences of the United States of America | 2016
Matilda Rentoft; Kristoffer Lindell; Phong Tran; Anna Lena Chabes; Robert J. Buckland; Danielle L. Watt; Lisette Marjavaara; Anna Karin Nilsson; Beatrice Melin; Johan Trygg; Erik Johansson; Andrei Chabes
Significance The three major DNA replication fidelity determinants are nucleotide selectivity, proofreading, and mismatch repair. Defects in the two latter determinants are now firmly associated with cancer. Nucleotide selectivity is affected by changes in the absolute or relative concentrations of dNTPs. Here, we show that hemizygous SAMHD1+/− mouse embryos have increased dNTP pools compared with wild-type controls and that heterozygous mutations that inactivate SAMHD1 are frequently found in colon cancers. We infer that such cancer cells have increased dNTP pools and, therefore, higher mutation rates. These observations suggest that changes in dNTP concentrations, which affect nucleotide selectivity, the first major determinant of DNA replication fidelity, are associated with cancer. Even small variations in dNTP concentrations decrease DNA replication fidelity, and this observation prompted us to analyze genomic cancer data for mutations in enzymes involved in dNTP metabolism. We found that sterile alpha motif and histidine-aspartate domain-containing protein 1 (SAMHD1), a deoxyribonucleoside triphosphate triphosphohydrolase that decreases dNTP pools, is frequently mutated in colon cancers, that these mutations negatively affect SAMHD1 activity, and that several SAMHD1 mutations are found in tumors with defective mismatch repair. We show that minor changes in dNTP pools in combination with inactivated mismatch repair dramatically increase mutation rates. Determination of dNTP pools in mouse embryos revealed that inactivation of one SAMHD1 allele is sufficient to elevate dNTP pools. These observations suggest that heterozygous cancer-associated SAMHD1 mutations increase mutation rates in cancer cells.
PLOS ONE | 2012
Matilda Rentoft; Philip J. Coates; Göran Laurell; Karin Nylander
Expression profiling techniques have been used to study the biology of many types of cancer but have been limited to some extent by the requirement for collection of fresh tissue. In contrast, formalin fixed paraffin embedded (FFPE) samples are widely available and represent a vast resource of potential material. The techniques used to handle the degraded and modified RNA from these samples are relatively new and all the pitfalls and limitations of this material for whole genome expression profiling are not yet clarified. Here, we analyzed 70 FFPE tongue carcinoma samples and 17 controls using the whole genome DASL array covering nearly 21000 genes. We identified that sample age is related to quality of extracted RNA and that sample quality influences apparent expression levels in a non-random manner related to gene probe sequence, leading to spurious results. However, by removing sub-standard samples and analysing only those 28 cancers and 15 controls that had similar quality we were able to generate a list of 934 genes significantly altered in tongue cancer compared to control samples of tongue. This list contained previously identified changes and was enriched for genes involved in many cancer-related processes such as tissue remodelling, inflammation, differentiation and apoptosis. Four novel genes of potential importance in tongue cancer development and maintenance, SH3BGL2, SLC2A6, SLC16A3 and CXCL10, were independently confirmed, validating our data. Hence, gene expression profiling can be performed usefully on archival material if appropriate quality assurance steps are taken to ensure sample consistency and we present some recommendations for the use of FFPE material based on our findings.
Journal of The European Academy of Dermatology and Venereology | 2013
Karin Danielsson; Linda Boldrup; Matilda Rentoft; Philip J. Coates; Majid Ebrahimi; Elisabet Nylander; Ylva Britt Wahlin; Karin Nylander
Background The pathogenesis of oral lichen planus (OLP), a chronic inflammatory disease, is not fully understood. It is known that OLP has autoimmune features, and it is suggested to be an autoimmune disease. ELF‐3 is involved in differentiation of keratinocytes and deregulated in different tumours and inflammatory diseases. CXCR‐3 and its ligands CXCL‐10 and CXCL‐11 are increased in autoimmune diseases and linked to Th‐1 immune response.
FEBS Journal | 2008
Matilda Rentoft; Kihoon Kim; Youngran Cho; Choon-Hwan Lee; AeRi Kim
Enhancers cause a high level of transcription and activation of chromatin structure at target genes. Hyperacetylation of histones H3 and H4, a mark of active chromatin, is established broadly across target loci by enhancers that function over long distances. In the present study, we studied the role of an enhancer in methylation of various lysine residues on H3 by comparing a model gene locus having an active enhancer with one in which the enhancer has been inactivated within the context of minichromosomes. The intact enhancer affected histone methylation at K4, K9 and K36 in distinct ways depending on the methylation level and the location in the locus. All three lysine residues were highly tri‐methylated in the coding region of the gene linked to the active enhancer but not the inactive enhancer. However di‐methylation of K9 and K36 was not affected by the enhancer. The enhancer region itself was marked by mono‐methylation at K4 and K9, distinguishing it from the methyl marks in the gene coding region. These results indicate that an enhancer has roles in establishing active histone methylation patterns linked with gene transcription rather than removing methylation linked with gene inactivation.
International Journal of Oncology | 2010
Matilda Rentoft; Jessica Fahlén; Philip J. Coates; Göran Laurell; Björn Sjöström; Patrik Rydén; Karin Nylander
Experimental and Therapeutic Medicine | 2010
Matilda Rentoft; Sara Hultin; Philip J. Coates; Göran Laurell; Karin Nylander
Tumor Biology | 2014
Matilda Rentoft; Philip J. Coates; Lotta Loljung; Torben Wilms; Göran Laurell; Karin Nylander
International Journal of Oncology | 2009
Matilda Rentoft; Göran Laurell; Philip J. Coates; Björn Sjöström; Karin Nylander
Oral Oncology | 2010
Matilda Rentoft; Göran Laurell; Philip J. Coates; Björn Sjöström; Karin Nylander
16th World Congress on Advances in Oncology and 14th International Symposium on Molecular Medicine October 6-8, 2011 Hotel Rodos Palace, Rhodes Island, Greece | 2011
Matilda Rentoft; Eva Johnsson; Göran Laurell; Philip J. Coates; Karin Nylander